 | • レポートコード：20QY06-02426 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、デフェラシロックスのグローバル市場について種類別（500mg/錠、250mg/錠、125mg/錠、その他）、用途別（輸血による鉄過剰、NTDTによる鉄過剰）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・デフェラシロックス市場の概要 ・世界の主要地域別デフェラシロックス市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のデフェラシロックス市場規模2015-2026：種類別（500mg/錠、250mg/錠、125mg/錠、その他） ・世界のデフェラシロックス市場規模2015-2026：用途別（輸血による鉄過剰、NTDTによる鉄過剰） ・デフェラシロックスの北米市場規模2015-2020 ・デフェラシロックスのヨーロッパ市場規模2015-2020 ・デフェラシロックスの中国市場規模2015-2020 ・デフェラシロックスの日本市場規模2015-2020 ・デフェラシロックスの東南アジア市場規模2015-2020 ・デフェラシロックスのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novartis、Cipla、Sun Pharma、Natco Pharma） ・デフェラシロックスの製造コスト分析 ・販売チャネル、流通業者、顧客 ・デフェラシロックスの市場動向・機会・課題 ・調査の結論 |
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias.
The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be taken orally unlike deferoxamine which has to be administered by IV route (intravenous infusion). Together with deferiprone, deferasirox seems to be capable of removing iron from cells (cardiac myocytes and hepatocytes) as well as removing iron from the blood. Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.
Market Analysis and Insights: Global Deferasirox Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Deferasirox market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Deferasirox industry.
Based on our recent survey, we have several different scenarios about the Deferasirox YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2491.2 million in 2019. The market size of Deferasirox will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Deferasirox Scope and Market Size
The global Deferasirox market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Deferasirox market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Deferasirox market is segmented into
500 mg/Tablet
250 mg/Tablet
125 mg/Tablet
Others
Segment by Application, the Deferasirox market is segmented into
Transfusional Iron Overload
NTDT Caused Iron Overload
The Deferasirox market is analysed and market size information is provided by regions (countries). Segment by Application, the Deferasirox market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Deferasirox Market Share Analysis
Deferasirox market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Deferasirox business, the date to enter into the Deferasirox market, Deferasirox product introduction, recent developments, etc.
The major vendors covered:
Novartis
Cipla
Sun Pharma
Natco Pharma
…
1 Deferasirox Market Overview
1.1 Deferasirox Product Scope
1.2 Deferasirox Segment by Type
1.2.1 Global Deferasirox Sales by Type (2020-2026)
1.2.2 500 mg/Tablet
1.2.3 250 mg/Tablet
1.2.4 125 mg/Tablet
1.2.5 Others
1.3 Deferasirox Segment by Application
1.3.1 Global Deferasirox Sales Comparison by Application (2020-2026)
1.3.2 Transfusional Iron Overload
1.3.3 NTDT Caused Iron Overload
1.4 Deferasirox Market Estimates and Forecasts (2015-2026)
1.4.1 Global Deferasirox Sales Growth Rate (2015-2026)
1.4.2 Global Deferasirox Revenue and Growth Rate (2015-2026)
1.4.3 Global Deferasirox Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Deferasirox Industry Impact
1.5.1 How the Covid-19 is Affecting the Deferasirox Industry
1.5.1.1 Deferasirox Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Deferasirox Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Deferasirox Players to Combat Covid-19 Impact
2 Deferasirox Estimate and Forecast by Region
2.1 Global Deferasirox Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Deferasirox Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Deferasirox Sales Market Share by Region (2015-2020)
2.2.2 Global Deferasirox Revenue Market Share by Region (2015-2020)
2.3 Global Deferasirox Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Deferasirox Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Deferasirox Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Deferasirox Estimates and Projections (2015-2026)
2.4.2 Europe Deferasirox Estimates and Projections (2015-2026)
2.4.3 China Deferasirox Estimates and Projections (2015-2026)
2.4.4 Japan Deferasirox Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Deferasirox Estimates and Projections (2015-2026)
2.4.6 India Deferasirox Estimates and Projections (2015-2026)
3 Global Deferasirox Competition Landscape by Players
3.1 Global Top Deferasirox Players by Sales (2015-2020)
3.2 Global Top Deferasirox Players by Revenue (2015-2020)
3.3 Global Deferasirox Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deferasirox as of 2019)
3.4 Global Deferasirox Average Price by Company (2015-2020)
3.5 Manufacturers Deferasirox Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Deferasirox Players (Opinion Leaders)
4 Global Deferasirox Market Size by Type
4.1 Global Deferasirox Historic Market Review by Type (2015-2020)
4.1.1 Global Deferasirox Sales Market Share by Type (2015-2020)
4.1.2 Global Deferasirox Revenue Market Share by Type (2015-2020)
4.1.3 Global Deferasirox Price by Type (2014-2020)
4.2 Global Deferasirox Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Deferasirox Sales Forecast by Type (2021-2026)
4.2.2 Global Deferasirox Revenue Forecast by Type (2021-2026)
4.2.3 Global Deferasirox Price Forecast by Type (2021-2026)
5 Global Deferasirox Market Size by Application
5.1 Global Deferasirox Historic Market Review by Application (2015-2020)
5.1.1 Global Deferasirox Sales Market Share by Application (2015-2020)
5.1.2 Global Deferasirox Revenue Market Share by Application (2015-2020)
5.1.3 Global Deferasirox Price by Application (2015-2020)
5.2 Global Deferasirox Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Deferasirox Sales Forecast by Application (2021-2026)
5.2.2 Global Deferasirox Revenue Forecast by Application (2021-2026)
5.2.3 Global Deferasirox Price Forecast by Application (2021-2026)
3 North America Deferasirox Market Facts & Figures
3.2 North America Deferasirox Sales Market Share by Company (2015-2020)
3.3 North America Deferasirox Sales Market Share by Type (2015-2020)
3.4 North America Deferasirox Sales Market Share by Application (2015-2020)
4 Europe Deferasirox Market Facts & Figures
4.2 Europe Deferasirox Sales Market Share by Company (2015-2020)
4.3 Europe Deferasirox Sales Market Share by Type (2015-2020)
4.4 Europe Deferasirox Sales Market Share by Application (2015-2020)
5 China Deferasirox Market Facts & Figures
5.2 China Deferasirox Sales Market Share by Company (2015-2020)
5.3 China Deferasirox Sales Market Share by Type (2015-2020)
5.4 China Deferasirox Sales Market Share by Application (2015-2020)
6 Japan Deferasirox Market Facts & Figures
6.2 Japan Deferasirox Sales Market Share by Company (2015-2020)
6.3 Japan Deferasirox Sales Market Share by Type (2015-2020)
6.4 Japan Deferasirox Sales Market Share by Application (2015-2020)
7 Southeast Asia Deferasirox Market Facts & Figures
7.2 Southeast Asia Deferasirox Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Deferasirox Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Deferasirox Sales Market Share by Application (2015-2020)
8 India Deferasirox Market Facts & Figures
8.2 India Deferasirox Sales Market Share by Company (2015-2020)
8.3 India Deferasirox Sales Market Share by Type (2015-2020)
8.4 India Deferasirox Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Deferasirox Business
12.1 Novartis
12.1.1 Novartis Deferasirox Corporation Information
12.1.2 Novartis Deferasirox Business Overview and Total Revenue
12.1.3 Novartis Deferasirox Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Deferasirox Products Offered
12.1.5 Novartis Recent Development
12.2 Cipla
12.2.1 Cipla Deferasirox Corporation Information
12.2.2 Cipla Deferasirox Business Overview and Total Revenue
12.2.3 Cipla Deferasirox Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cipla Deferasirox Products Offered
12.2.5 Cipla Recent Development
12.3 Sun Pharma
12.3.1 Sun Pharma Deferasirox Corporation Information
12.3.2 Sun Pharma Deferasirox Business Overview and Total Revenue
12.3.3 Sun Pharma Deferasirox Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sun Pharma Deferasirox Products Offered
12.3.5 Sun Pharma Recent Development
12.4 Natco Pharma
12.4.1 Natco Pharma Deferasirox Corporation Information
12.4.2 Natco Pharma Deferasirox Business Overview and Total Revenue
12.4.3 Natco Pharma Deferasirox Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Natco Pharma Deferasirox Products Offered
12.4.5 Natco Pharma Recent Development
…
13 Deferasirox Manufacturing Cost Analysis
13.1 Deferasirox Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Deferasirox
13.4 Deferasirox Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Deferasirox Distributors List
14.3 Deferasirox Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Deferasirox Sales (M Tablets) Growth Rate by Type (2020-2026)
Table 2. Global Deferasirox Sales (M Tablets) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Deferasirox Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Deferasirox Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Deferasirox Players to Combat Covid-19 Impact
Table 8. Global Market Deferasirox Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Deferasirox Sales (M Tablets) by Region (2015-2020)
Table 10. Global Deferasirox Sales Market Share by Region (2015-2020)
Table 11. Global Deferasirox Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Deferasirox Revenue Share by Region (2015-2020)
Table 13. Global Deferasirox Sales (M Tablets) Forecast by Region (2021-2026)
Table 14. Global Deferasirox Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Deferasirox Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Deferasirox Revenue Share Forecast by Region (2021-2026)
Table 17. Global Deferasirox (M Tablets) of Key Companies (2015-2020)
Table 18. Global Deferasirox Sales Share by Company (2015-2020)
Table 19. Global Deferasirox Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Deferasirox Revenue Share by Company (2015-2020)
Table 21. Global Deferasirox by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deferasirox as of 2019)
Table 22. Global Deferasirox Average Price (USD/Tablet) of Key Company (2015-2020)
Table 23. Manufacturers Deferasirox Manufacturing Sites and Area Served
Table 24. Manufacturers Deferasirox Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Deferasirox Players
Table 27. Global Deferasirox Sales (M Tablets) by Type (2015-2020)
Table 28. Global Deferasirox Sales Share by Type (2015-2020)
Table 29. Global Deferasirox Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Deferasirox Price (M Tablets) by Type (2015-2020)
Table 31. Global Deferasirox Sales Share by Type (2021-2026)
Table 32. Global Deferasirox Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Deferasirox Revenue Share by Type (2021-2026)
Table 34. Global Deferasirox Price (M Tablets) by Type (2021-2026)
Table 35. Global Deferasirox Sales (M Tablets) by Application (2015-2020)
Table 36. Global Deferasirox Sales Share by Application (2015-2020)
Table 37. Global Deferasirox Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Deferasirox Price (M Tablets) by Application (2015-2020)
Table 39. Global Deferasirox Sales (M Tablets) by Application (2021-2026)
Table 40. Global Deferasirox Sales Share by Application (2021-2026)
Table 41. Global Deferasirox Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Deferasirox Revenue Share by Application (2021-2026)
Table 43. Global Deferasirox Price (M Tablets) by Application (2021-2026)
Table 44. United States Deferasirox Sales (M Tablets) by Company (2015-2020)
Table 45. United States Deferasirox Sales Market Share by Company (2015-2020)
Table 46. United States Deferasirox Sales (M Tablets) by Type (2015-2020)
Table 47. United States Deferasirox Sales Market Share by Type (2015-2020)
Table 48. United States Deferasirox Sales (M Tablets) by Application (2015-2020)
Table 49. United States Deferasirox Sales Market Share by Application (2015-2020)
Table 50. Europe Deferasirox Sales (M Tablets) by Company (2015-2020)
Table 51. Europe Deferasirox Sales Market Share by Company (2015-2020)
Table 52. Europe Deferasirox Sales (M Tablets) by Type (2015-2020)
Table 53. Europe Deferasirox Sales Market Share by Type (2015-2020)
Table 54. Europe Deferasirox Sales (M Tablets) by Application (2015-2020)
Table 55. Europe Deferasirox Sales Market Share by Type (2015-2020)
Table 56. China Deferasirox Sales (M Tablets) by Company (2015-2020)
Table 57. China Deferasirox Sales Market Share by Company (2015-2020)
Table 58. China Deferasirox Sales (M Tablets) by Type (2015-2020)
Table 59. China Deferasirox Sales Market Share by Type (2015-2020)
Table 60. China Deferasirox Sales (M Tablets) by Application (2015-2020)
Table 61. China Deferasirox Sales Market Share by Application (2015-2020)
Table 62. Japan Deferasirox Sales (M Tablets) by Company (2015-2020)
Table 63. Japan Deferasirox Sales Market Share by Company (2015-2020)
Table 64. Japan Deferasirox Sales (M Tablets) by Type (2015-2020)
Table 65. Japan Deferasirox Sales Market Share by Type (2015-2020)
Table 66. Japan Deferasirox Sales (M Tablets) by Application (2015-2020)
Table 67. Japan Deferasirox Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Deferasirox Sales (M Tablets) by Company (2015-2020)
Table 69. Southeast Asia Deferasirox Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Deferasirox Sales (M Tablets) by Type (2015-2020)
Table 71. Southeast Asia Deferasirox Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Deferasirox Sales (M Tablets) by Type (2015-2020)
Table 73. Southeast Asia Deferasirox Sales Market Share by Application (2015-2020)
Table 74. India Deferasirox Sales (M Tablets) by Company (2015-2020)
Table 75. India Deferasirox Sales Market Share by Company (2015-2020)
Table 76. India Deferasirox Sales (M Tablets) by Type (2015-2020)
Table 77. India Deferasirox Sales Market Share by Type (2015-2020)
Table 78. India Deferasirox Sales (M Tablets) by Application (2015-2020)
Table 79. India Deferasirox Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 83. Novartis Deferasirox Product
Table 84. Novartis Recent Development
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 88. Cipla Deferasirox Product
Table 89. Cipla Recent Development
Table 90. Sun Pharma Corporation Information
Table 91. Sun Pharma Description and Business Overview
Table 92. Sun Pharma Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 93. Sun Pharma Deferasirox Product
Table 94. Sun Pharma Recent Development
Table . Natco Pharma Corporation Information
Table . Natco Pharma Description and Business Overview
Table . Natco Pharma Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2015-2020)
Table . Natco Pharma Deferasirox Product
Table . Natco Pharma Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Deferasirox Distributors List
Table 103. Deferasirox Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Deferasirox Product Picture
Figure 2. Global Deferasirox Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Deferasirox Market Share by Application in 2020 & 2026
Figure 6. Transfusional Iron Overload Examples
Figure 7. NTDT Caused Iron Overload Examples
Figure 8. Global Deferasirox Sales (M Tablets) Growth Rate (2015-2026)
Figure 9. Global Deferasirox Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Deferasirox Price Trends Growth Rate (2015-2026) (USD/Tablet)
Figure 11. Global Deferasirox Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Deferasirox Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Deferasirox Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Deferasirox Sales (M Tablets) Growth Rate (2015-2026)
Figure 15. Europe Deferasirox Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Deferasirox Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Deferasirox Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Deferasirox Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Deferasirox Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Deferasirox Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Deferasirox Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Deferasirox Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Deferasirox Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Deferasirox Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Deferasirox Players Market Share by Revenue in Deferasirox 2015 & 2019
Figure 26. Deferasirox Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Deferasirox Revenue Share by Type (2015-2020)
Figure 28. Global Deferasirox Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Deferasirox Revenue Share by Application (2015-2020)
Figure 30. Global Deferasirox Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Deferasirox Sales Market Share by Type in 2019
Figure 32. United States Deferasirox Sales Market Share by Type in 2019
Figure 33. Europe Deferasirox Sales Market Share by Company in 2019
Figure 34. Europe Deferasirox Sales Market Share by Type in 2019
Figure 35. Europe Deferasirox Sales Market Share by Application in 2019
Figure 36. China Deferasirox Sales Market Share by Company in 2019
Figure 37. China Deferasirox Sales Market Share by Type in 2019
Figure 38. China Deferasirox Sales Market Share by Application in 2019
Figure 39. Japan Deferasirox Sales Market Share by Company in 2019
Figure 40. Japan Deferasirox Sales Market Share by Type in 2019
Figure 41. Japan Deferasirox Sales Market Share by Application in 2019
Figure 42. Southeast Asia Deferasirox Sales Market Share by Company in 2019
Figure 43. Southeast Asia Deferasirox Sales Market Share by Type in 2019
Figure 44. Southeast Asia Deferasirox Sales Market Share by Application in 2019
Figure 45. India Deferasirox Sales Market Share by Company in 2019
Figure 46. India Deferasirox Sales Market Share by Type in 2019
Figure 47. India Deferasirox Sales Market Share by Application in 2019
Figure 48. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Natco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Deferasirox
Figure 54. Manufacturing Process Analysis of Deferasirox
Figure 55. Deferasirox Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Porter's Five Forces Analysis
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
デフェラシロックスの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Deferasirox market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 3034.2 million by 2025, from USD 2563.3 million in 2019. The Deferasirox mark…- 鉄キレート剤の世界市場レポート2020 This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely t…
- デフェリプロンの世界市場レポート2020 Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload. The proportio…
- 過負荷リレーの世界市場レポート2020 Market Analysis and Insights: Global Overload Relays Market The global Overload Relays market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Overload Relays Scope and Market Size The global Overload Relays mark…
- 発泡錠の世界市場レポート2020 Effervescent tablets are designed to break in contact with liquid such as water or juice, often causing the tablet to dissolve into a solution. Market Analysis and Insights: Global Effervescent Tablet Market The global Effervescent Tablet market was valued at US$ xx million in 2019 and will reach US…